The impact of simultaneous measurement of testosterone and androstenedlone in women with suspected androgen excess [9]

Clinical Chemistry

Volumn 53, Issue 4, 2007, Pages 804-805

  Duxbury, Katherine ^a,b   Gallagher, Louise ^a   Keevil, Brian ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; HYDROXYPROGESTERONE; TESTOSTERONE;

ACNE; ANOVULATION; BIOCHEMISTRY; CONCENTRATION RESPONSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIRSUTISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERANDROGENISM; LETTER; MENSTRUAL IRREGULARITY; OVARY POLYCYSTIC DISEASE; PREDICTION; TESTOSTERONE RELEASE;

ANDROGENS; ANDROSTENEDIONE; FEMALE; HUMANS; TESTOSTERONE;

EID: 34147201548     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.083782     Document Type: Letter

References (5)

1. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004;89:453-62.
2. Marthur RS, Moody LO, Landgrebbe S, Williamson HO. Plasma androgens and sex hormone binding globulin in the evaluation of hirsute patients. Fertil Steril 1981;35:29-37.
3. Burger HG. Androgen production in women. Fertil Steril 2002;77:S3-5.
4. Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 1974;39:340.
5. The Rotterdam ESHRE/ASRM-sponsored Consensus Workshop Group: revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.